NIH #3P30CA082709-14S5
Clinical Pharmacology Analytical Core
- Amount
- $7K
- Period
- — → 2015-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at INDIANA UNIVERSITY INDIANAPOLIS
Lung Cancer Diagnosis and Treatment · Pulmonary and Respiratory Medicine
13 total · 0 active
NIH #3P30CA082709-14S5
Awarded at INDIANA UNIVERSITY INDIANAPOLIS
NIH #3P30CA082709-14S3
Awarded at INDIANA UNIVERSITY INDIANAPOLIS
NIH #3P30CA082709-14S4
Awarded at INDIANA UNIVERSITY INDIANAPOLIS
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Cancers · 2026-01-08
Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive Treatment
JAMA Network Open · 2025-12-09 · 1 citations
Journal of Thoracic and Cardiovascular Surgery · 2025-12-05
2025-11-26
Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025-11-26
Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025-11-26
2025-11-26
Supplementary Data from Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer
2025-11-26
2025-11-25
2025-11-25
The Annals of Thoracic Surgery · 2025-11-05 · 5 citations
ESMO Real World Data and Digital Oncology · 2025-11-01
P3.01.22 Deep Learning-Based CT Analysis Enhances Lung Cancer Risk Prediction in Never Smoking Women
Journal of Thoracic Oncology · 2025-10-01
Journal of Thoracic Oncology · 2025-10-01
The role of diagnostic laparoscopy in staging distal esophageal adenocarcinoma
JTCVS Open · 2025-09-23 · 1 citations
Journal of Thoracic and Cardiovascular Surgery · 2025-09-20 · 5 citations
Annals of Surgery · 2025-09-12
British Journal of Anaesthesia · 2025-09-11
Resectable non−small cell lung cancer in women: A disease-specific entity?
JTCVS Open · 2025-09-11 · 1 citations
Cancer · 2025-09-09 · 4 citations